Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids

Life Sciences

Volumn 74, Issue 1, 2003, Pages 47-53

  Wolfram, Roswitha M ^a   Chehne, Fahdi ^a,d   Oguogho, Anthony ^a,e   Sinzinger, Helmut ^a,b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^c Inst Diagn Treatm Lipid D   (Austria)

^d UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^e AMBROSE ALLI UNIVERSITY   (Nigeria)

Author keywords

Haemostasis; Isoprostanes; Oxidation injury; Platelet function; Prostaglandins; Thromboxane; Water pipe

Indexed keywords

11 OXOTHROMBOXANE B2; 8 ISOPROSTAGLANDIN E2; ICOSANOID; MALONALDEHYDE;

ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; ELECTRIC POTENTIAL; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; OXIDATION; THROMBOCYTE FUNCTION;

EID: 0142248477     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.06.020     Document Type: Article

References (19)

1. Church D.F., Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environmental Health Perspectives. 64:1985;111-126.
2. Cosgrove J.P., Borish E.T., Church D.F., Pryor W.A. The metal-mediated formation of hydroxyl radical by aqueous extracts of cigarette tar. Biochemical Biophysical Research Communications. 132:1985;390-396.
3. 2α: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. British Journal of Clinical Pharmacology. 42:1986;15-19.
4. 2-isoprostane, on endothelin-I release. Journal of Cardiovascular Pharmacology. 26:1995;551-552.
5. 2-isoprostanes, are present in increased amounts of human atherosclerotic lesions. Arteriosclerosis Thrombosis and Vascular Biology. 17:1997;3236-3241.
6. Gotto A.M. Jr. Interactions of the major risk factors for coronary heart disease. American Journal of Medicine. 80:1986;48-55.
7. 2α. British Journal of Pharmacology. 119:1996;1276-1280.
8. Krupski W.C. The peripheral vascular consequence of smoking. Annual Vascular Surgery. 5:1991;91-95.
9. Leitinger N., Blazek I., Sinzinger H. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets. Thrombosis Research. 86:1997;337-342.
10. 2α, is accumulated in coronary arteries isolated from patients with coronary heart disease. Cardiovascular Research. 43:1999;492-499.
11. 2-isoprostanes during oxidation of human low-density lipoproteins and plasma by peroxynitrite. Circulation Research. 77:1995;335-341.
12. Morrow J.D., Hill K.E., Bukr R.F., Nammour T.M., Badr K.F., Roberts L.J. II A series of prostaglandin F2-like compounds are produced in vivo in human by a non-cyclooxygenase free radical-catalyzed mechanism. Proceedings Natural Academy of Sciences USA. 87:1990;9383-9387.
13. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. New England Journal of Medicine. 332:1995;1198-1203.
14. 2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vessels. Prostaglandins and Other Lipid Mediators. 57:1999;269-279.
15. Oguogho A., Kritz H., Sinzinger H. Einmaliges Passivrauchen induziert keine messbare Oxidation der low-density Lipoproteine. Wiener klinische Wochenschrift. 108:1996;589-592.
16. 2α in human atherosclerotic vascular tissue. Prostaglandins Leukotrienes and Essential Fatty Acids. 60:1999;129-134.
17. Oguogho A., Lupattelli G., Palumbo B., Sinzinger H. Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults. VASA. 29:2000;103-105.
18. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in-vivo in chronic cigarette smokers. Circulation. 94:1996;19-25.
19. 2 - ein neuer Analyt zur Bestimmung der aktuellen Thromboxankonzentration im Plasma. Journal of Clinical Chemistry and Clinical Biochemistry. 26:1988;776.